8Lun·

Then there is still plenty of room

At $NKTR (-5,41 %) until the new price target. Let's stick with it then.


BTIG has set the rating for Nektar (NASDAQ: NKTR) to 'buy'. The price target is $151.0000 after $118.0000 previously.

Prior to this rating, 7 analysts have rated Nektar with a buy rating and 1 with a hold rating. There were 0 Sell recommendations.

Analyst consensus estimates and price targets for Nektar can be found at hier. Further news on Nektar can be found hier.

Nektar's share price ended the official trading session at a closing price of $37.07. The stock's performance was up 1.3400% in the last month and up 431.1600% in the last 12 months.

According to Investing Pro the Fair Value of Nektar is $35.6395. This corresponds to a downside risk of 48.3500%. InvestingPro rates the uncertainty surrounding Nektar's fair value as "high".

7
11 Comentarios

Imagen de perfil
I got nervous and sold. But it was only 13x
•
1
•
Imagen de perfil
••
@Multibagger Do you think you can still buy them after a setback? I am unsure and would like to hold for 2 to 3 years. Do you still see a chance?
•
1
•
Imagen de perfil
@Multibagger yes today. I bought them on January 5 at €38 shortly before they fell to €30. I will get back in if there is a setback. Biotech is always a rollercoaster ride.
•
1
•
Imagen de perfil
@Panda0404 Yes, you can, maybe wait for things to calm down
•
1
•
Imagen de perfil
@Multibagger will you stay in ... or will you take the flash with you and possibly get back in later?
•
1
•
Imagen de perfil
@forestgump stay in for now
••
Imagen de perfil
@Multibagger i sell it ... get back in if there is a reset ... or get annoyed that the wild ride continues without me 😉
•
2
•
Imagen de perfil
@forestgump the funds released go 50:50 to $IREN and $SOFI
•
1
•
Imagen de perfil
@forestgump you were probably a little too hasty.
••
Imagen de perfil
@Multibagger You're right 🙈
••
Únase a la conversación